栄研化学(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4549/E00961 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2013/08/30 | 日証協 | 170,466株 | -3.84% | 5,688株 | -94.69% | 186,813株 | -3.95% | 3,035株 | -87.14% |
2013/08/23 | 日証協 | 177,266株 | -1.83% | 107,039株 | +237.52% | 194,503株 | -2.52% | 23,606株 | -57.63% |
2013/08/16 | 日証協 | 180,566株 | -8.6% | 31,713株 | -78.28% | 199,527株 | -4.18% | 55,712株 | +46.2% |
2013/08/09 | 日証協 | 197,566株 | -2.23% | 146,021株 | +226.82% | 208,234株 | -1.29% | 38,106株 | -12.42% |
2013/08/02 | 日証協 | 202,066株 | -4.27% | 44,679株 | -59.7% | 210,947株 | -4.36% | 43,509株 | +37.18% |
2013/07/26 | 日証協 | 211,078株 | -5.21% | 110,876株 | +3.44% | 220,559株 | -1.1% | 31,717株 | -58.73% |
2013/07/19 | 日証協 | 222,670株 | +10.64% | 107,192株 | -31.11% | 223,004株 | +7.89% | 76,847株 | -10.4% |
2013/07/12 | 日証協 | 201,253株 | +1.42% | 155,602株 | +12.39% | 206,687株 | +7.44% | 85,768株 | +150% |
2013/07/05 | 日証協 | 198,443株 | +0.86% | 138,449株 | +102.13% | 192,377株 | +4.62% | 34,307株 | +129.92% |
2013/06/28 | 日証協 | 196,743株 | -2.33% | 68,495株 | +29.19% | 183,886株 | -10.46% | 14,921株 | -53.33% |
2013/06/21 | 日証協 | 201,431株 | -3.9% | 53,020株 | -53.68% | 205,364株 | -10.88% | 31,970株 | -71.55% |
2013/06/14 | 日証協 | 209,600株 | +3.12% | 114,464株 | +87.34% | 230,445株 | -5.44% | 112,382株 | +23.17% |
2013/06/07 | 日証協 | 203,264株 | +5.9% | 61,098株 | +6.59% | 243,696株 | +4.85% | 91,243株 | +106.9% |
2013/05/31 | 日証協 | 191,935株 | +4.06% | 57,323株 | -54.5% | 232,428株 | +6.64% | 44,101株 | -55.13% |
2013/05/24 | 日証協 | 184,453株 | -4.85% | 125,975株 | -31.29% | 217,962株 | -8.27% | 98,290株 | -54.34% |
2013/05/17 | 日証協 | 193,852株 | +98.01% | 183,333株 | +3.51% | 237,622株 | +20.41% | 215,276株 | +21.84% |
2013/05/10 | 日証協 | 97,900株 | +69.35% | 177,122株 | +75.61% | 197,342株 | +77.05% | 176,691株 | +170.58% |
2013/05/02 | 日証協 | 57,810株 | +45.47% | 100,862株 | -10.24% | 111,460株 | +45.83% | 65,300株 | +196.95% |
2013/04/26 | 日証協 | 39,740株 | +64.71% | 112,374株 | +175.21% | 76,432株 | +4.6% | 21,990株 | +67.24% |
※株式分割は考慮していませんのでご注意ください。
Page Top